While it is possible that loss of Akt2 might predispose mice to lung cancer independently of hyperactive insulin signaling, studies to understand the role of hyperglycemia in lung cancer progression are needed especially considering diabetes is a prevalent disease whose incidence is increasing globally [53]. This evidence concerns the gene AKT2 and lung carcinoma.